RE: HUA and Desktop Review23 Nov 2021 08:44
Medusa are not manufacturing. If they were, we’d have an RNS, despite the NDA. Besides, the NDA appears to have been upheld by Avacta alone given Medusa have declared MeduFlow last week, and manufacturing strategies to PI’s over the phone.
ABDX and Medusa are not delivering anything material at present. All rumour and conjecture until we hear otherwise.
At this price, we’re huge value if any one of those comes off. Add in AVA. The market has no clue how to deal with us, other than ride this current cyclic wave.
For me, positive AVA news before Christmas will be a monstrous reversal in credibility for AS. It’s puts the disappointment of failed timelines and promises for the LFT to bed. We’ll know that they were a product of HMG/market.
We’ve got a big 4 weeks in the offing.